Alimera Enterprise Value Multiple from 2010 to 2024

ALIM Stock  USD 3.97  0.07  1.79%   
Alimera Sciences Enterprise Value Multiple yearly trend continues to be very stable with very little volatility. Enterprise Value Multiple is likely to grow to 23.92 this year. During the period from 2010 to 2024, Alimera Sciences Enterprise Value Multiple quarterly data regression pattern had sample variance of  227.75 and median of (2.38). View All Fundamentals
 
Enterprise Value Multiple  
First Reported
2010-12-31
Previous Quarter
22.77849687
Current Value
23.92
Quarterly Volatility
15.09129417
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Alimera Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alimera main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.2 M, Interest Expense of 10.7 M or Selling General Administrative of 11.1 M, as well as many exotic indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.0125 or Operating Cycle of 335. Alimera financial statements analysis is a perfect complement when working with Alimera Sciences Valuation or Volatility modules.
  
This module can also supplement Alimera Sciences' financial leverage analysis and stock options assessment as well as various Alimera Sciences Technical models . Check out the analysis of Alimera Sciences Correlation against competitors.
To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.

Latest Alimera Sciences' Enterprise Value Multiple Growth Pattern

Below is the plot of the Enterprise Value Multiple of Alimera Sciences over the last few years. It is Alimera Sciences' Enterprise Value Multiple historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alimera Sciences' overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Multiple10 Years Trend
Slightly volatile
   Enterprise Value Multiple   
       Timeline  

Alimera Enterprise Value Multiple Regression Statistics

Arithmetic Mean2.30
Geometric Mean5.07
Coefficient Of Variation655.93
Mean Deviation11.79
Median(2.38)
Standard Deviation15.09
Sample Variance227.75
Range50.574
R-Value0.45
Mean Square Error194.87
R-Squared0.21
Significance0.09
Slope1.53
Total Sum of Squares3,188

Alimera Enterprise Value Multiple History

2024 23.92
2023 22.78
2022 -6.49
2021 25.61
2020 25.29
2019 -24.97
2018 -10.77

About Alimera Sciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Alimera Sciences income statement, its balance sheet, and the statement of cash flows. Alimera Sciences investors use historical funamental indicators, such as Alimera Sciences's Enterprise Value Multiple, to determine how well the company is positioned to perform in the future. Although Alimera Sciences investors may use each financial statement separately, they are all related. The changes in Alimera Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alimera Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Alimera Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Alimera Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Enterprise Value Multiple 22.78  23.92 

Pair Trading with Alimera Sciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alimera Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alimera Sciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Alimera Stock

  0.63URGN UroGen Pharma Financial Report 9th of May 2024 PairCorr
  0.47MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
  0.46MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
The ability to find closely correlated positions to Alimera Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alimera Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alimera Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alimera Sciences to buy it.
The correlation of Alimera Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alimera Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alimera Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alimera Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Alimera Sciences is a strong investment it is important to analyze Alimera Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alimera Sciences' future performance. For an informed investment choice regarding Alimera Stock, refer to the following important reports:
Check out the analysis of Alimera Sciences Correlation against competitors.
To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Alimera Stock analysis

When running Alimera Sciences' price analysis, check to measure Alimera Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alimera Sciences is operating at the current time. Most of Alimera Sciences' value examination focuses on studying past and present price action to predict the probability of Alimera Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alimera Sciences' price. Additionally, you may evaluate how the addition of Alimera Sciences to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Is Alimera Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.84)
Revenue Per Share
3.159
Quarterly Revenue Growth
0.875
Return On Assets
(0.01)
Return On Equity
(1.59)
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.